Proteomics: A Promising Approach for Cancer Research Volume 2 Proteome signaling dysregulation in cancer, therapeutic interventions, and future perspectives provides an updated overview of scientific knowledge, achievements, and findings in the field of cancer proteomics. The field of cancer proteomics is very dynamic, with emerging trends specifically related to clinical solutions. The book content was developed to help readers get up to speed on the topic and easily apply learnings into research or clinical practice.Volume 2 covers proteome signaling, their dysregulation to therapeutics options and future prospects in 17 different signaling pathways. It capitalizes the enormous interest in proteomics among academics and gives new viewpoints on this topic in cancer treatment. It is a valuable resource for cancer researchers, oncologists, graduate students, and members of biomedical field who are interested in the potential of proteomics in cancer research and treatment. - Provides up to date information on current cancer proteomics research developed globally- Presents from basic research aspects to clinical implications of proteomics on cancer diagnosis and potential treatments- Discusses challenges and future developments of the field to leverage further research and applicability in clinical setting- Contains exclusive information about research on proteome signaling dysregulation in cancer and therapies globally- Includes recent details which will be the prerequisite requirement for any researcher who wants to work on cancer proteomics, proteome signaling dysregulation and therapeutics
